Research Highlights

New Neurology Update from Palliative Care is in! Read more about the topics here

Palliative care outpatient clinics, with a multidisciplinary team, helps patients with Parkinson’s disease and related disorders and their families.

Event Related Potentials might be an accurate neurophysiological biomarker for early diagnosis of AD and prediction of MCI to AD conversion.

Two patients with severe PML have been successfully treated with BK virus-specific T cells at Hannover Medical School's Department of Neurology, according to director, Prof. Günter Höglinger.

Archeological neuroimmunology- pathogenic immune response from a case of more than 60 years ago characterized from archival brain tissue

Neurology Update: Epilepsy

Neurology Update: Coordinating Panel on Rare Neurological Diseases

Neurology Update: Rare Diseases

Patients using angiotensin-II-stimulating antihypertensives have 45% lower risk to develop demenia compared to those that use angiotensin-II-inhibiting antihypertensives.

Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders

Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Longitudinal neuroimaging biomarkers differacross Alzheimer’s disease phenotypes

Auditory localization should be considered as a sign of consciousness, as unresponsive patients who demonstrate this behaviour show increased brain activity and better outcomes, comparable to patients in minimally conscious state.

The process of end-of-life decision-making for patients with disorders of consciousness should include caregivers in bedside assessments and integrate advanced diagnostic brain imaging techniques when available.

An international study showed that younger age, shorter time since injury, higher level of responsiveness and EEG reactivity to eye opening are all factors that can predict 6-month improvement among severely brain-injured patients.